Correlation Between CompuGroup Medical and Gilead Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CompuGroup Medical and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CompuGroup Medical and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CompuGroup Medical AG and Gilead Sciences, you can compare the effects of market volatilities on CompuGroup Medical and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CompuGroup Medical with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CompuGroup Medical and Gilead Sciences.

Diversification Opportunities for CompuGroup Medical and Gilead Sciences

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between CompuGroup and Gilead is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding CompuGroup Medical AG and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and CompuGroup Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CompuGroup Medical AG are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of CompuGroup Medical i.e., CompuGroup Medical and Gilead Sciences go up and down completely randomly.

Pair Corralation between CompuGroup Medical and Gilead Sciences

Assuming the 90 days trading horizon CompuGroup Medical AG is expected to generate 1.19 times more return on investment than Gilead Sciences. However, CompuGroup Medical is 1.19 times more volatile than Gilead Sciences. It trades about 0.29 of its potential returns per unit of risk. Gilead Sciences is currently generating about 0.12 per unit of risk. If you would invest  1,383  in CompuGroup Medical AG on August 31, 2024 and sell it today you would earn a total of  216.00  from holding CompuGroup Medical AG or generate 15.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CompuGroup Medical AG  vs.  Gilead Sciences

 Performance 
       Timeline  
CompuGroup Medical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CompuGroup Medical AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, CompuGroup Medical may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Gilead Sciences 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Gilead Sciences unveiled solid returns over the last few months and may actually be approaching a breakup point.

CompuGroup Medical and Gilead Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CompuGroup Medical and Gilead Sciences

The main advantage of trading using opposite CompuGroup Medical and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CompuGroup Medical position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.
The idea behind CompuGroup Medical AG and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon